Document is current
Any future updates will be listed below
-
Authors
Zhang, Yu-qiong
Su, Ning
Huang, Lan
Xu, Wei-dong
Wang, Ya-nan
Gao, Jing-jing
-
Funding
Funding for this research was provided by:
Suzhou Key Laboratory of Intelligent Critical Illness Biomarkers Translational Research (SZS2024029, SZS2024029, SZS2024029, SZS2024029, SZS2024029)
Suzhou Medical and Health Technology Innovation Project (SYWD2025145; SYWD2024326, SYWD2025145; SYWD2024326, SYWD2025145; SYWD2024326, SYWD2025145; SYWD2024326, SYWD2025145; SYWD2024326, SYWD2025145; SYWD2024326)
Nanjing Medical University - Qilu Clinical Research Fund Project (2024KF0258, 2024KF0258, 2024KF0258, 2024KF0258, 2024KF0258)
- License Information
-
More Information
Article History
Received: 15 June 2025
Accepted: 7 October 2025
First Online: 31 October 2025
Declarations
:
: The study protocol was approved by the Ethics Committee of The Affiliated Suzhou Hospital of Nanjing Medical University (Approval No. K-2024-144-K01). This is a retrospective study. The need for informed consent was waived by the Ethics Committee of The Affiliated Suzhou Hospital of Nanjing Medical University. This study was conducted in full accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
